Selective Laser Trabeculoplasty and the Evolving Glaucoma Paradigm

Area of Science:

• Ophthalmology
• Glaucoma Management
• Medical Therapeutics

Background:

• The traditional glaucoma management approach relies heavily on topical medications.
• Patient adherence to topical glaucoma medications is often suboptimal, impacting treatment efficacy.
• Complex factors contribute to poor medication adherence in glaucoma patients.

Purpose of the Study:

• To re-evaluate the long-standing topical medications-first approach in glaucoma management.
• To explore novel therapeutic options that can bypass topical medications.
• To advocate for a paradigm shift towards primary selective laser trabeculoplasty (SLT).

Main Methods:

• Review of the strengths and limitations of topical medical therapy for glaucoma.
• Analysis of new and emerging data supporting alternative treatment strategies.
• Discussion of patient communication regarding selective laser trabeculoplasty (SLT).

Main Results:

• Topical medications, while safe and effective, suffer from poor patient adherence.
• Novel therapies like sustained-release platforms, SLT, and minimally invasive glaucoma surgery offer alternatives to topical treatments.
• Moving away from topical therapy has the potential to improve long-term glaucoma outcomes due to enhanced adherence.

Conclusions:

• A paradigm shift to primary selective laser trabeculoplasty (SLT) is appropriate for most glaucoma patients.
• Primary SLT offers a viable alternative to topical therapy, potentially overcoming adherence challenges.
• Integrating primary SLT into clinical practice can lead to better long-term glaucoma management and patient outcomes.